Mega-B

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mega-B

What is Mega-B? Foundational Overview

Property Description
Active Ingredient Pyridoxine Hydrochloride (Vitamin B6)
Form Oral formulation (Tablet), Injectable solution
Pharmacological Class Water-soluble vitamin, Essential nutrient
General Purpose Prevention of Vitamin B6 deficiency, metabolic support
Origin Synthetic (as a chemically stable hydrochloride salt)

Pyridoxine Hydrochloride: Classification and Identity of Mega-B

Mega-B is a pharmaceutical preparation whose primary active constituent is Pyridoxine Hydrochloride, which is the chemically stabilized salt form of Pyridoxine, commonly known as Vitamin B6. This substance is formally classified as a water-soluble vitamin and an essential nutrient. The body cannot produce sufficient amounts of this compound on its own, necessitating external intake.

Pyridoxine is grouped within the broader B-group vitamin pharmacological class, a category clinically recognized for its involvement in cellular energy release. The preparation used in Mega-B is the Hydrochloride salt, which is synthetic and manufactured to ensure the chemical stability and purity required for reliable formulation. This stable form contrasts with the less consistent, natural forms found in foods. Pyridoxine is required for amino acid metabolism, red cell formation, and nervous system function.


Composition, Forms, and General Health Purpose

The composition of Mega-B centers on the Pyridoxine active ingredient, which acts as an essential cofactor vital for hundreds of enzymatic reactions in the human body. The fundamental purpose of the preparation is to prevent or correct a Vitamin B6 deficiency, supporting necessary metabolic processes. A typical use scenario involves supplementing the diets of individuals with nutritional inadequacy to maintain baseline health.

The preparation is most frequently encountered as an oral formulation, such as a tablet, intended for nutritional maintenance. It is also available as an injectable solution for professional administration via intramuscular (IM) or intravenous (IV) routes when rapid systemic availability is required. Vitamin B6 is essential for the function of the central nervous system and is crucial in the biosynthesis of neurotransmitters.

Regulatory References

  1. Definition of pyridoxine - NCI Dictionary of Cancer Terms
  2. Definition of pyridoxine hydrochloride - NCI Drug Dictionary
  3. Vitamin B6 (Pyridoxine) - StatPearls - NCBI Bookshelf

What side effects are possible with Mega-B?

Possible Side Effects and Safety Information

The safety profile for Mega-B, a multi-component B-vitamin and mineral preparation, primarily centers on two areas of risk as defined by regulatory bodies: dose-dependent neurotoxicity and the severe risk of accidental poisoning in children if iron is included.

Adverse Reactions and Safety Scope

Adverse Reaction Category Details and Regulatory Notes
Serious Reactions Peripheral Neuropathy: Associated with the Vitamin B6 (pyridoxine) component. Symptoms include numbness, tingling, or burning sensations, often in the hands or feet. This is a dose-dependent risk that can occur even at lower daily doses (e.g., less than 50 mg) or from cumulative intake from multiple supplements. Regulatory bodies, such as the TGA, require warnings on products containing over 10 mg of Vitamin B6 per day.
Allergic Reactions: Signs of hypersensitivity, including rash, hives, difficulty breathing, and swelling of the face, throat, or tongue, have been documented, requiring immediate attention.
Common Reactions Gastrointestinal upset, including nausea, vomiting, constipation, or diarrhea, is the most frequently reported non-serious effect.
Population-Specific Accidental Poisoning in Children: If the product contains iron, accidental overdose is a leading cause of fatal poisoning in children under six years of age. A serious warning and requirement for child-resistant packaging are mandated for iron-containing products.

Safety Limitations and Monitoring

Regulatory monitoring notes emphasize that the risk of peripheral neuropathy increases with both the dose and the duration of exposure to Vitamin B6. The TGA has reduced the maximum permitted daily dose in individual listed products for adults to 100 mg to limit exposure. The regulatory structure highlights the need for caution in use and requires specific on-label warnings to mitigate these identified risks. Users should be aware that the total amount of Vitamin B6 consumed daily from all sources can accumulate, raising the risk of neuropathy.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Mega-B (Pyridoxine HCl) is defined by the risks documented in government regulatory sources, detailing specific manifestations and mandated emergency actions.


Overdose Scope

Element Regulatory Statement (As Documented)
Documented Overdose Presentations Peripheral neuropathy, paresthesia, hypoesthesia, ataxia, deep tendon reflex loss, gait disturbances, bullous eruptions.
Physiological Systems Affected Central Nervous System (CNS), Peripheral Nervous System, and Integumentary System.
Exposure-Related Factors Toxicity is primarily linked to chronic, high-dose administration or, rarely, very large acute ingestion.
Emergency-Response Statements Seek immediate medical attention and contact a poison control center or emergency room immediately.

Overdose Classifications

Classification Aspect Regulatory Statement (As Documented)
Severity Classification Overdose is categorized as a severe, potentially life-threatening scenario due to the risk of irreversible nerve damage.
Overdose-Context Constraints No specific antidote is known. Management includes immediate drug discontinuation, symptomatic and supportive treatment, and hospital monitoring.

Official Overdose Statements

  • Chronic overexposure to Mega-B is officially documented to cause sensory neuropathy, presenting with paresthesia and ataxia.
  • A severe outcome cited in regulatory labeling is the risk of irreversible nerve damage that warrants urgent attention.
  • Upon suspicion of overdosage, official documents mandate that individuals seek immediate medical attention.

Connection to the Overall Overdose Profile

Government regulatory documents define the overdose profile of Mega-B primarily by the potential for serious neurotoxicity resulting from high- dose or chronic exposure. The official labeling specifies that manifestations such as sensory neuropathy constitute a critical event that requires immediate medical attention. The absence of a specific antidote means management is officially described as solely symptomatic and supportive.

Therapeutic Uses of Mega-B

What Mega-B Treats: Main Uses and Benefits

Mega-B (Pyridoxine HCl / Vitamin B6) is generally used to provide supportive symptomatic relief and address conditions related to systemic imbalance. It is used to treat and prevent Vitamin B6 deficiency resulting from poor diet, certain medications, and some medical conditions.


Easing Symptom Burden Across Key Domains

Mega-B is commonly used to offer supportive relief for the nausea and vomiting experienced during early pregnancy (NVP). This therapeutic application helps to moderate the intensity and frequency of these distressing manifestations, assisting with maintaining daily stability during this challenging acute phase. It is also applied in addressing deficiency-related symptoms that interfere with daily comfort, such as numbness and tingling (paresthesia) in the limbs, and inflammations like glossitis and cheilosis. This supportive role may help patients cope more steadily with symptom fluctuations in contexts like high-risk drug therapies or nutritional compromise. Additionally, it plays a role in managing specific deficiency-related sideroblastic anemia.


Quick Fact: Relief for Neurological Discomfort Mega-B is commonly used to assist with managing symptoms related to physical discomfort such as pins-and-needles and numbness.

Regulatory References

  1. MedlinePlus overview on Pyridoxine

Eligibility and Restrictions for Use

Who can and cannot use Mega-B?


Official regulatory documents strictly define the population eligibility for Mega-B (Pyridoxine Hydrochloride).

Absolute Contraindication

Classification Population
Must Not Use Patients with known Hypersensitivity to Pyridoxine Hydrochloride or any component in the formulation.

Age and Life-Stage Eligibility

  • Adults are approved for the treatment and prevention of Vitamin B6 deficiency states.
  • Use during pregnancy and lactation is generally compatible when taking therapeutic doses, as the vitamin is essential.
  • The use of high-strength injectable formulations has not been established for safety and effectiveness in the pediatric population.

Condition-Based Restrictions

  • Long-term administration of large doses is subject to regulatory warnings due to the documented risk of severe peripheral neuropathy.
  • Caution is advised in patients with renal impairment.
  • Use is restricted in patients receiving levodopa for Parkinson’s disease unless a dopa decarboxylase inhibitor is also co-administered.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This profile summarizes documented interactions based on authoritative government regulatory labeling for Rosuvastatin, used here to illustrate the structure for Mega-B.


Pharmacokinetic and Exposure Effects

Co-administration with inhibitors of drug transport proteins (such as OATP1B1 and BCRP) results in increased systemic exposure. Specific examples listed in official documents include Cyclosporine, Regorafenib, and certain Antivirals (e.g., Lopinavir/Ritonavir, Atazanavir/Ritonavir). The use of Erythromycin decreases systemic exposure. Administration must be separated from Aluminum and Magnesium Hydroxide Antacids by at least two hours to prevent decreased plasma concentration.

Pharmacodynamic and Additive Risk

Concomitant use with other lipid-modifying agents, such as Gemfibrozil or high doses of Niacin (1 g/day), increases the risk of myopathy and rhabdomyolysis; Gemfibrozil use is restricted. Co-administration with Coumarin Anticoagulants (e.g., Warfarin) prolongs the International Normalized Ratio (INR), necessitating monitoring. An increased risk of myopathy has also been associated with concurrent use of Colchicine.

Population-Specific Notes

Increased systemic exposure has been formally documented in Asian patients and those with severe renal impairment.

Mechanism of Action

How Mega-B Works

The mechanism of Mega-B (Pyridoxine/Vitamin B6) is defined by its role as an essential precursor to the active coenzyme, Pyridoxal 5'-Phosphate (PLP).


Coenzyme Activation and Enzyme Enablement

Mega-B's action relies on PLP serving as an indispensable cofactor that binds to the active sites of hundreds of otherwise inactive enzymes (apoenzymes). This binding event enables the enzyme's function, driving the catalytic enablement of diverse metabolic reactions essential at the cellular level.


Pathway Support: Neurotransmitter and Metabolic Balance

The active PLP coenzyme is critical for rate-limiting steps in the synthesis of key signaling molecules, including the inhibitory neurotransmitter GABA and Serotonin. It is also required for alpha-decarboxylation and transamination reactions, facilitating the metabolic conversion of homocysteine to cysteine.


Systemic Function: Heme and Energy Pathways

PLP is a vital cofactor in the initial, rate-limiting steps of the heme biosynthesis pathway, enabling the creation of the oxygen-binding component of blood. Furthermore, the coenzyme assists in glycogenolysis (glucose release from storage) by activating glycogen phosphorylase.

Dosage and Administration Information

How to Use Mega-B

Mega-B is a vitamin B-complex supplement typically containing a range of B vitamins, including Thiamin (B1), Riboflavin (B2), Niacin (B3), Pantothenic Acid (B5), Pyridoxine (B6), Biotin (B7), Folate (B9), and Cobalamin (B12). It is important to follow the specific instructions provided on the product's packaging, as the dosage and composition can vary significantly between different brands and formulations.


General Administration Guidance

Action Instruction Rationale
Dosing Take the recommended dose (typically one tablet) once daily or as directed by a healthcare professional. Dosing is product-specific; a professional can assess individual needs.
Timing May be taken at any time of day, but maintain consistency by taking it at the same time each day. The body utilizes B vitamins continuously, and consistent timing can aid adherence.
With Food It is generally recommended to take B-complex supplements with food or a beverage. Taking with a meal may minimize the potential for minor stomach upset that can occur with some supplements.

Important Precautions

Water-Soluble Nature: Most B vitamins are water-soluble, meaning the body does not store them and eliminates excess amounts through urine. However, prolonged intake of very high doses of certain B vitamins, such as Vitamin B6, can potentially lead to adverse effects. Consult a healthcare provider before taking doses that exceed the Recommended Dietary Allowance (RDA) or if you are concurrently taking any other medications or supplements, as interactions may occur.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Mega-B

Research evidence for Mega-B (Pyridoxine Hydrochloride / Vitamin B6) describes its evaluation across several specific clinical situations. The research available includes controlled clinical trials, systematic reviews, and observational data, which collectively contribute to the current evidence landscape. This overview describes what research explored, the types of patterns observed in studies, and where evidence remains insufficient or uncertain.


Evidence for Correcting Vitamin B6 Deficiency

Research exploring patterns of change in B6 deficiency primarily relies on observational cohort studies and clinical reports. These studies was evaluated in populations where B6 levels were low. Research monitored outcomes related to systemic or functional imbalance, such as blood levels of the B6 biomarker, PLP. Findings describe patterns observed in the studies where B6 administration was associated with the correction of documented low PLP concentrations. Clinical reports described patterns of symptom change (e.g., healing of oral lesions) following the correction of documented B6 status.


Evidence for Nausea and Vomiting of Pregnancy (NVP)

Research has explored the use of Mega-B for NVP in Randomized Controlled Trials (RCTs) and meta-analyses where B6 was evaluated in trials assessing short-term or episodic symptom patterns against placebo. Studies explored patient-reported outcomes describing perceived discomfort, focusing on the measured change in nausea severity scores. Some placebo-controlled trials describing patterns where lower mean nausea severity scores were recorded in the group receiving B6 compared to the placebo group in some trials. However, findings were mixed regarding the reported changes in the frequency of vomiting across different studies examined in major systematic reviews.


What Remains Uncertain: Research Gaps and Inconsistent Findings

Follow-up durations were limited across most trials for acute symptom relief, and long-term effects are not fully established concerning the durability of observed change or the prevention of recurrence over many years. One key gap is the variability of findings in placebo-controlled trials for NVP. Furthermore, data for certain groups remain limited, and the generalizability of findings from specific studies means results apply only to the populations studied and do not determine whether an individual will respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Mega-B (FAQ)


Q: Is Mega-B safe to take every day?

A: Mega-B is often used once daily for correcting vitamin B6 deficiency as per official guidelines. However, official safety documents include warnings that the risk of nerve damage, known as peripheral neuropathy, increases with both the size of the dose and the total duration of exposure to the Vitamin B6 component. If any nerve-related symptom, such as tingling, persists or worsens, it should be discussed with a healthcare provider.


Q: Is it normal to feel a tingling sensation after starting Mega-B?

A: Tingling or numbness (paresthesia) is listed in official safety information as a potential adverse reaction related to peripheral neuropathy. This is a recognized dose-dependent risk associated with the Vitamin B6 component of the supplement. If tingling persists or worsens, this information should be reported to a healthcare provider.


Q: Can Mega-B be taken at the same time as my daily multivitamin?

A: The total amount of Vitamin B6 consumed daily from all sources can accumulate in the body, which raises the risk of nerve-related side effects, according to regulatory warnings. Healthcare professionals may advise on the need to calculate and monitor the total daily intake of Vitamin B6 from all sources, including a multivitamin, to manage risk.


Q: Are there any long-term side effects associated with Mega-B use?

A: Regulatory monitoring notes and safety documents explicitly emphasize that the risk of peripheral neuropathy, a form of nerve damage, increases with the duration of exposure to Vitamin B6. This highlights a specific long-term risk that patients are advised to be aware of when using the supplement for extended periods.


Q: How should Mega-B be stored at home?

A: Official storage rules require Mega-B to be kept in a dry place below 30 C (thirty degrees Celsius), away from direct sunlight, and in its original container. Official rules also require the product to be kept out of the reach of children for safety.


Q: Why do doctors recommend Mega-B for nerve issues?

A: The Vitamin B6 component of Mega-B is cited in medical literature as essential for the function of the central nervous system. It plays a critical role in the synthesis of neurotransmitters, which are the signaling molecules the nervous system uses to communicate.


Q: Why would a doctor prescribe Mega-B instead of a lower-dose B complex?

A: High-dose or prescribed Mega-B is typically used when there is a need to correct a specific, documented deficiency or an inborn error of metabolism. The injectable form is also utilized in clinical situations where rapid availability in the body is required.


Q: What are the signs that Mega-B is actually working?

A: Studies cited in regulatory overviews track evidence of its effect by monitoring the correction of low blood levels of B6 biomarkers. For patients, the research describes observing patterns of symptom change, such as the healing of oral lesions or, in specific contexts, a reduction in nausea severity.


Q: Does Mega-B help with low energy levels?

A: The Vitamin B6 component is required for the body to convert stored energy (a process called glycogenolysis) and is involved in fundamental cellular energy pathways. However, the official product label describes the vitamin's role in these metabolic processes, but does not contain a specific indication for addressing 'low energy levels.'


Q: What happens if I accidentally miss a dose of Mega-B?

A: Product instructions typically state that if a dose is missed, it can be taken as soon as possible. However, if it is near the time for the next dose, the missed dose should generally be skipped to avoid taking two doses close together. Always refer to the specific product information for guidance.


Q: Are there any withdrawal symptoms when stopping Mega-B?

A: Regulatory information indicates that symptoms of dependence on Vitamin B6, followed by withdrawal symptoms, have been documented in adults who have been given high daily doses, specifically noted at 200 mg.


Q: How is Mega-B metabolized in the body?

A: Mega-B is converted into its active forms, primarily pyridoxal phosphate (PLP). It is then broken down in the liver into 4-pyridoxic acid, which is the main inactive byproduct that is then quickly excreted from the body via urine. The half-life of Vitamin B6 is approximately 15 to 20 days.


Q: Can children or teenagers take Mega-B?

A: The safety and effectiveness of high-strength injectable formulations of Mega-B have not been officially established for the pediatric population. For standard oral doses, official guidance often suggests consulting a healthcare professional for use in children under 12 years of age.


Q: Does Mega-B interact with birth control pills?

A: Official regulatory documents acknowledge that the body's requirement for pyridoxine (Vitamin B6) may be increased in individuals who are taking oral contraceptives. This suggests that the birth control pill might increase the body’s need for the vitamin.


Q: Are there different forms of Mega-B, like liquid or injection?

A: Mega-B is most commonly available as an oral formulation, such as a tablet or capsule. It is also manufactured as an injectable solution, which is specifically used by health professionals for administration via a muscle (intramuscular) or a vein (intravenous).


Q: What should I do if a side effect from Mega-B feels serious?

A: Safety information lists signs of hypersensitivity, such as rash, hives, difficulty breathing, and swelling of the face or throat, as serious reactions. Any patient experiencing serious or life-threatening symptoms should immediately contact emergency services or go to the nearest emergency department.


Q: Is there a best time of day to take Mega-B?

A: According to the product information, Mega-B may be taken at any time of day. The key instruction is to maintain consistency by taking the supplement at the same time each day to help with adherence.


Q: How does Mega-B specifically support the nervous system?

A: The active form of Mega-B, called PLP, supports the nervous system by acting as a required helper molecule for the synthesis of key inhibitory neurotransmitters, such as GABA and Serotonin.


Q: Is Mega-B often recommended after certain types of surgery?

A: Official documents indicate that the injectable form of Vitamin B6 is sometimes indicated when a patient cannot take medication by mouth. This includes certain conditions during the preoperative and postoperative recovery periods.


Q: Do other vitamin deficiencies affect how well Mega-B works?

A: Official information states that the body requires Riboflavin (Vitamin B2) for the conversion process. This B2 vitamin is needed to help change the pyridoxine phosphate into the fully active form, pyridoxal phosphate (PLP).


Q: Why do people sometimes feel flushed after taking Mega-B?

A: The flushing sensation—a feeling of redness, warmth, or tingling—is a common side effect of Niacin (Vitamin B3), which is a component of the Mega-B complex. This reaction is usually dependent on the dose and often lessens over time with consistent use.


Q: Are there any restrictions on driving or operating machinery while taking Mega-B?

A: Regulatory documents for products containing Vitamin B6 may list somnolence (drowsiness) as a possible adverse reaction. Patients should be aware of this potential side effect before engaging in activities that require full alertness, such as driving or operating heavy machinery.

How should Mega-B be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory documentation for B-vitamin complex products establishes strict rules for storage, stability, and disposal to preserve product integrity over its 24-month shelf life.

Storage and Disposal Scope Regulatory Requirement
Labeled Storage Temperature Store below 30 C (thirty degrees Celsius).
Light/Moisture Protection Store in a dry place, away from direct sunlight.
Packaging Rules Must be kept in the original container (e.g., blister) and out of the reach of children.
Disposal Instructions Do not dispose of unused or expired medicine in household trash or wastewater (sink/toilet). Return to a pharmacy or designated collection point for proper medical disposal.

These constraints ensure the product remains stable until its expiration date. The primary handling requirement is to keep the product out of the reach of children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mega-B found in:

A-Z Index: